Skip to Main Content

An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

About this Publication
Title
Weakly-supervised preclinical tumor localization associated with survival prediction from lung cancer screening Chest X-ray images.
Pubmed ID
38729092 (View this publication on the PubMed website)
Digital Object Identifier
Publication
Comput Med Imaging Graph. 2024 May 7; Volume 115: Pages 102395
Authors
Hermoza R, Nascimento JC, Carneiro G
Affiliations
  • Australian Institute for Machine Learning, The University of Adelaide, Australia. Electronic address: renato.hermozaaragones@adelaide.edu.au.
  • Institute for Systems and Robotics (ISR/IST), LARSyS, Instituto Superior Técnico, Universidade de Lisboa, Portugal. Electronic address: jan@isr.tecnico.ulisboa.pt.
  • Centre for Vision, Speech and Signal Processing (CVSSP), The University of Surrey, UK. Electronic address: g.carneiro@surrey.ac.uk.
Abstract

In this paper, we hypothesize that it is possible to localize image regions of preclinical tumors in a Chest X-ray (CXR) image by a weakly-supervised training of a survival prediction model using a dataset containing CXR images of healthy patients and their time-to-death label. These visual explanations can empower clinicians in early lung cancer detection and increase patient awareness of their susceptibility to the disease. To test this hypothesis, we train a censor-aware multi-class survival prediction deep learning classifier that is robust to imbalanced training, where classes represent quantized number of days for time-to-death prediction. Such multi-class model allows us to use post-hoc interpretability methods, such as Grad-CAM, to localize image regions of preclinical tumors. For the experiments, we propose a new benchmark based on the National Lung Cancer Screening Trial (NLST) dataset to test weakly-supervised preclinical tumor localization and survival prediction models, and results suggest that our proposed method shows state-of-the-art C-index survival prediction and weakly-supervised preclinical tumor localization results. To our knowledge, this constitutes a pioneer approach in the field that is able to produce visual explanations of preclinical events associated with survival prediction results.

Related CDAS Studies
Related CDAS Projects